ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
0.00%
S&P ASX All Technology
2,968.80
0.00%
Brent Oil
83.54
-2.74%
US Dollar vs AUD
1.53259
-0.75%
Bitcoin
58,229.00
-3.90%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Calliditas Therapeutics AB (CALT)

  7. Calliditas Therapeutics AB (CALT) News

CALT Calliditas Therapeutics AB

19.9399
0.00 (0.00%)
After Hours
Last Updated: 08:39:10
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Calliditas Therapeutics AB CALT NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 19.9399 08:39:10
Open Price Low Price High Price Close Price Previous Close
19.50 19.29 19.50 19.9399 19.9399
more quote information »

Recent News

Date Time Source Heading
25/4/202403:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
25/4/202403:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24/4/202417:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
24/4/202417:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
18/4/202421:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
18/4/202421:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
09/4/202421:24PRNUSCalliditas Therapeutics to Attend Conferences in April
09/4/202421:22PRNUSCalliditas Therapeutics to Attend Conferences in April
08/4/202422:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202422:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202417:24PRNUSCalliditas receives notice of allowance for United States..
08/4/202417:22PRNUSCalliditas receives notice of allowance for United States..
12/3/202412:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
06/3/202418:38PRNUSCalliditas announces an additional seven year orphan drug..
06/3/202418:34PRNUSCalliditas announces an additional seven year orphan drug..
01/3/202423:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
01/3/202423:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
21/2/202417:45PRNUSCalliditas Year-end report, January - December 2023
21/2/202417:43PRNUSCalliditas Year-end report, January - December 2023
14/2/202417:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
14/2/202417:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
14/2/202403:28PRNUSCalliditas provides patent update
14/2/202403:26PRNUSCalliditas provides patent update
09/1/202400:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202418:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
08/1/202418:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
08/1/202403:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
08/1/202403:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
08/1/202403:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
08/1/202403:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
28/12/202308:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/12/202304:22PRNUSCalliditas refinances existing term loan with Euro 92..
28/12/202304:16PRNUSCalliditas refinances existing term loan with Euro 92..
21/12/202311:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
21/12/202309:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
21/12/202309:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202308:34PRNUSCalliditas Therapeutics announces full FDA approval of..
21/12/202308:33PRNUSCalliditas Therapeutics announces full FDA approval of..
12/12/202301:40PRNUSCalliditas Receives Notice of Allowance for United States..
12/12/202301:38PRNUSCalliditas Receives Notice of Allowance for United States..
01/12/202319:27PRNUSCalliditas announces additions to the management team
01/12/202319:21PRNUSCalliditas announces additions to the management team
30/11/202318:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
30/11/202318:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
24/11/202319:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
24/11/202319:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
08/11/202302:31PRNUSCalliditas to present at upcoming investor conferences
08/11/202302:29PRNUSCalliditas to present at upcoming investor conferences
07/11/202317:32PRNUSCalliditas Interim Report January - September 2023
07/11/202317:29PRNUSCalliditas Interim Report January - September 2023

Your Recent History

NASDAQ
CALT
Calliditas Therapeutics AB
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved